Buy or sell: Stock recommendation by brokers for September 5, 2025 – The Times of India
Nuvama initiated coverage on Neuland Laboratories with the target price at Rs 17,700. Analysts said peptides are expected to drive growth post-FY28, while the company’s Unit III expansion is the key lever till that year. Its pipeline of drugs, peptide facility to support growth beyond FY28, and a pick-up in growth is expected from Oct-Mar…